Patient and Physician Perceptions of Prostate-Specific Antigen Testing Among Black Individuals

作者：Jenney R. Lee, Danté Morehead, Ben Young, Victor Tolbert, John Masembe, Garrett Britt, Lars Neuenschwander, Kyle Schuppe, Richard S. Pelman, Debi Johnson, Vida Henderson, Burcu F. Darst, Patricia Egwuatu, Sung Min Kim, Erika M. Wolff, John L. Gore, Yaw A. Nyame · 发表于：JAMA Network Open · 年份：2025 · DOI：10.1001/jamanetworkopen.2025.30946 · 被引用次数：3 · 研究领域：Prostate Cancer Diagnosis and Treatment、Global Cancer Incidence and Screening、Prostate Cancer Treatment and Research

Importance: Black individuals have a twofold higher rate of prostate cancer death in the US compared with the average population with prostate cancer. Few guidelines support race-conscious screening practices among at-risk Black individuals. Objective: To examine structural factors that facilitate or impede access to prostate cancer screening among Black individuals in the US. Design, Setting, and Participants: This qualitative, mixed-methods study was conducted between September 1, 2021, and December 31, 2023, in clinical and community settings across Washington, Wyoming, Alaska, Montana, Idaho, and Oregon. It included semistructured interviews with Black adults (aged ≥18 years) at risk for prostate cancer with or without a history of prostate-specific antigen (PSA) testing and a survey of primary care practitioners (PCPs) and urologists. Main Outcomes and Measures: Patient and physician experiences, knowledge, attitudes, and practices of PSA testing and prostate cancer screening were evaluated. Consensus coding and thematic analysis were used to analyze interviews; surveys were analyzed using descriptive statistics. Results: A total of 29 Black men (median [range] age, 59 [32-72] years) participated in the interviews, and 31 PCPs (including 30 phyicians and 1 physician assistant) and 32 urologists (45 of 63 aged 30-59 years [71.4%]; 40 male [63.5%]) participated in the survey. Interview participants perceived that PCPs function as gatekeepers in accessing PSA testing but ma...